| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Engervall, K, et al.
(författare)
-
Borreliosis as a cause of peripheral facial palsy: a multi-center study
- 1995
-
Ingår i: ORL. - 0301-1569. ; 57:4, s. 202-206
-
Tidskriftsartikel (refereegranskat)abstract
- Borreliosis is known to be a common cause of peripheral facial palsy in Stockholm and its vicinity. The aim of the present study was to investigate the frequency and characteristics of borreliosis among patients with peripheral facial palsy in different parts of Sweden. All serological tests were performed in one laboratory. Ten Swedish Ear Nose and Throat clinics participated in a prospective 1-year study of patients seeking medical attention for acute peripheral facial palsy. Twenty-eight (6%) out of totally 446 patients fulfilled the criteria for the diagnosis of borreliosis. The frequency varied between 1 and 16% and was highest along the southeast coast of Sweden whereas no case was reported from the northern part of the country. Borreliosis was more common among children with facial palsy than among adults. The infection occurred during all seasons although it appears to be less frequent during the spring months. Only a minority of the borrelial patients had a history of a preceding tick bite or erythema migrans. The fairly low overall frequency of this secondary stage of borreliosis in the study may be a result of better knowledge of the disease and earlier treatment of its early manifestations. In Sweden's endemic areas borreliosis is a common cause of peripheral facial palsy, and therefore all patients with facial palsy in these regions should be examined for borrelial infection.
|
|
| 5. |
- Schulman, S., et al.
(författare)
-
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months
- 2006
-
Ingår i: Journal of Thrombosis and Haemostasis. - : Elsevier BV. - 1538-7933 .- 1538-7836. ; 4:4, s. 734-742
-
Tidskriftsartikel (refereegranskat)abstract
- Background: The influence of the duration of anticoagulant therapy after venous thromboembolism (VTE) on the long-term morbidity and mortality is unclear. Aim: To investigate the long-term sequelae of VTE in patients randomized to different duration of secondary prophylaxis. Methods: In a multicenter trial comparing secondary prophylaxis with vitamin K antagonists for 6 weeks or 6 months, we extended the originally planned 2 years follow-up to 10 years. The patients had annual visits and at the last visit clinical assessment of the post-thrombotic syndrome (PTS) was performed. Recurrent thromboembolism was adjudicated by a radiologist, blinded to treatment allocation. Causes of death were obtained from the Swedish Death Registry. Results: Of the 897 patients randomized, 545 could be evaluated at the 10 years follow-up. The probability of developing severe PTS was 6% and any sign of PTS was seen in 56.3% of the evaluated patients. In multivariate analysis, old age and signs of impaired circulation at discharge from the hospital were independent risk factors at baseline for development of PTS after 10 years. Recurrent thromboembolism occurred in 29.1% of the patients with a higher rate among males, older patients, those with permanent gering risk factor - especially with venous insufficiency at baseline - signs of impaired venous circulation at discharge, proximal deep vein thrombosis, or pulmonary embolism. Death occurred in 28.5%, which was a higher mortality than expected with a standardized incidence ratio (SIR) of 1.43 (95% CI 1.28-1.58), mainly because of a higher mortality than expected from cancer (SIR 1.83, 95% CI 1.44-2.23) or from myocardial infarction or stroke (SIR 1.28, 95% CI 1.00-1.56).The duration of anticoagulation did not have a statistically significant effect on any of the long-term outcomes. Conclusion: The morbidity and mortality during 10 years after the first episode of VTE is high and not reduced by extension of secondary prophylaxis from 6 weeks to 6 months. A strategy to reduce recurrence of VTE as well as mortality from arterial disease is needed. © 2006 International Society on Thrombosis and Haemostasis.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Nordlander, Johan, et al.
(författare)
-
Reactive objects
- 2002
-
Ingår i: Fifth IEEE International Symposium on Object-Oriented Real-Time Distributed Computing. - Piscataway, NJ : IEEE Communications Society. ; , s. 155-158
-
Konferensbidrag (refereegranskat)abstract
- Object-oriented, concurrent, and event-based programming models provide a natural framework in which to express the behavior of distributed and embedded software systems. However, contemporary programming languages still base their I/O primitives on a model in which the environment is assumed to be centrally controlled and synchronous, and interactions with the environment carried out through blocking subroutine calls. The gap between this view and the natural asynchrony of the real world has made event-based programming a complex and error-prone activity, despite recent focus on event-based frameworks and middleware. In this paper we present a consistent model of event-based concurrency, centered around the notion of reactive objects. This model relieves the object-oriented paradigm from the idea of transparent blocking, and naturally enforces reactivity and state consistency. We illustrate our point by a program example that offers substantial improvements in size and simplicity over a corresponding Java-based solution.
|
|
